What’s the current market cap for ConvaTec Group stock?

ConvaTec Group (CTEC) has a market cap of £4bn as of June 15, 2026.

What is the P/E ratio for ConvaTec Group stock?

The price to earnings (P/E) ratio for ConvaTec Group (CTEC) stock is 31.68 as of June 15, 2026.

Does ConvaTec Group stock pay dividends?

Yes, the ConvaTec Group (CTEC) stock pays dividends to shareholders. As of June 15, 2026, the dividend rate is £0.05372 and the yield is 2.64%. ConvaTec Group has a payout ratio of 80% on a trailing twelve-month basis.

When is the next ConvaTec Group dividend payment date?

The next ConvaTec Group (CTEC) dividend payment date is unconfirmed.

What is the beta indicator for ConvaTec Group?

ConvaTec Group (CTEC) has a beta rating of 0.78. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy ConvaTec Group stock | £CTEC Share Price

07:00

09:10

11:15

13:25

15:30

About ConvaTec Group

Ticker

£CTEC

Sector

Health

Primary listing

LSE

Employees

10,910

Headquarters

London, United Kingdom

Website

www.convatecgroup.com

ConvaTec Group Metrics

BasicAdvanced

£4bn

31.68

£0.06

0.78

£0.05

2.64%

What the Analysts think about ConvaTec Group

Analyst ratings (Buy, Hold, Sell) for ConvaTec Group stock.

Bulls say / Bears say

The company increased its medium-term organic revenue growth target to 6%–8% from 5%–7%, reflecting a stronger product pipeline and management’s belief in improving chronic-care performance (Reuters)

ConvaTec recorded its fifth straight year of organic revenue growth in FY2025, reaching 6.4% growth excluding InnovaMatrix, expanding its operating margin by 110 basis points to 22.3%, and achieving 16% adjusted EPS growth, pointing to solid profitability gains (Reuters)

New product rollouts, such as advanced wound-care dressings, along with operational streamlining and a larger presence in North America and Europe, are broadening revenue sources and strengthening the chronic-care pipeline (Reuters)

Organic revenue growth for the first four months of 2026 including InnovaMatrix reached only 1.6%, missing the Visible Alpha consensus estimate of about 2.8%, indicating short-term pressure on the top line (Reuters)

Structural shifts in the US skin substitutes market and Medicare reimbursement cuts for InnovaMatrix caused an approximate 300 basis-point negative impact on organic growth, underscoring reimbursement risks tied to specific products (Reuters)

Management cautioned that rising costs from geopolitical tensions, especially due to the Iran conflict, could drive up operating expenses and may require a guidance revision if conditions worsen (Reuters)

Data summarised monthly by Lightyear AI. Last updated on 31 May 2026.

ConvaTec Group Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

ConvaTec Group Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Market data provided by London Stock Exchange, through Infront.

Buy £CTEC

Capital at risk

Market closed

Upcoming events

No upcoming events

Bulls say / Bears say

Data summarised monthly by Lightyear AI. Last updated on 31 May 2026.

About ConvaTec Group

Ticker

Primary listing

Employees

ConvaTec Group Metrics

Price and volume

Financial strength

Profitability

Management effectiveness

Valuation

Growth

What the Analysts think about ConvaTec Group

Analyst Ratings

Bulls say / Bears say

ConvaTec Group Financial Performance

Income Statement

ConvaTec Group Earnings Performance

Earnings per share (EPS)

Buy £CTEC

Upcoming events

No upcoming events

Lightyear

Legal

Work with us

Bulls say / Bears say

ConvaTec Group/£CTEC

About ConvaTec Group

Ticker

Primary listing

Employees

ConvaTec Group Metrics

Price and volume

Financial strength

Profitability

Management effectiveness

Valuation

Growth

What the Analysts think about ConvaTec Group

Analyst Ratings

Bulls say / Bears say

ConvaTec Group Financial Performance

Income Statement

ConvaTec Group Earnings Performance

Earnings per share (EPS)

Buy £CTEC

Upcoming events

No upcoming events

What’s the current market cap for ConvaTec Group stock?

What is the P/E ratio for ConvaTec Group stock?

Does ConvaTec Group stock pay dividends?

When is the next ConvaTec Group dividend payment date?

What is the beta indicator for ConvaTec Group?

Bulls say / Bears say